Page last updated: 2024-08-25

rosiglitazone and Acute Kidney Injury

rosiglitazone has been researched along with Acute Kidney Injury in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's5 (55.56)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Bi, R; Cao, Q; Cui, X; Gao, X; Lin, Y; Liu, S; Quan, F; Su, Y; Wang, Y; Yang, Y; Yue, C; Zhang, D; Zhang, M; Zhao, Q1
Chen, E; Huang, J; Wu, J; Zheng, X1
Chen, Y; Dai, Y; Gao, H; Huang, Y; Jin, R; Mo, D; Yan, Q; Zhang, C; Zhang, L1
Dias, C; Helou, CM; Volpini, RA1
Deng, J; Yu, J2
Ji, K; Wang, H; Wang, R; Wu, X; Yan, Z; Zang, B1
Abdul Ghani, R; Kamaruddin, NA; Kong, NC; Zainudin, S1
Cho, WY; Jo, SK; Kim, HK; Kim, HW; Kim, MG; Yang, HN1

Trials

1 trial(s) available for rosiglitazone and Acute Kidney Injury

ArticleYear
Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR
    Disease markers, 2022, Volume: 2022

    Topics: Acute Kidney Injury; Animals; Caspase 3; Creatinine; Furosemide; Interleukin-10; Iohexol; Kidney; Nitrogen; NLR Family, Pyrin Domain-Containing 3 Protein; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Urea

2022

Other Studies

8 other study(ies) available for rosiglitazone and Acute Kidney Injury

ArticleYear
ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
    Redox biology, 2022, Volume: 51

    Topics: Acute Kidney Injury; Animals; Coenzyme A Ligases; Female; Ferroptosis; Humans; Male; Mice; Rosiglitazone

2022
Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
    Communications biology, 2023, 09-05, Volume: 6, Issue:1

    Topics: Acute Kidney Injury; Animals; Cell Death; Epithelial Cells; Fibrosis; Humans; Mice; Neurodegenerative Diseases; Rosiglitazone

2023
Rosiglitazone did not induce acute kidney injury in normocholesterolemic rats despite reduction in glomerular filtration rate.
    Kidney & blood pressure research, 2013, Volume: 38, Issue:2-3

    Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Cholesterol; Glomerular Filtration Rate; Hypercholesterolemia; Hypoglycemic Agents; Lipid Metabolism; Lipocalin-2; Lipocalins; Magnesium; Male; Proto-Oncogene Proteins; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Thiobarbituric Acid Reactive Substances

2013
[Effects of rosiglitazone on levels of TNFα in septic rats with acute kidney injury].
    Zhonghua yi xue za zhi, 2015, May-19, Volume: 95, Issue:19

    Topics: Acute Kidney Injury; Animals; Cecum; Disease Models, Animal; Inflammation; Kidney; Ligation; Male; Punctures; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Thiazolidinediones; Tumor Necrosis Factor-alpha

2015
Rosiglitazone attenuates renal injury caused by hyperlipidemic pancreatitis.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:5

    Topics: Acute Kidney Injury; Animals; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hyperlipidemias; Hypoglycemic Agents; Immunohistochemistry; In Situ Nick-End Labeling; Male; Pancreatitis; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones

2015
[Rosiglitazone protects acute kidney injury in septic rats].
    Zhonghua yi xue za zhi, 2016, Aug-02, Volume: 96, Issue:29

    Topics: Acute Kidney Injury; Animals; Apoptosis; Blotting, Western; Cecum; Kidney; Ligation; Male; Peroxidase; PPAR gamma; Punctures; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Thiazolidinediones

2016
Acute renal failure following the use of rosiglitazone in a chronic kidney disease patient.
    Singapore medical journal, 2009, Volume: 50, Issue:1

    Topics: Acute Kidney Injury; Aged; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Mycophenolic Acid; Renal Dialysis; Rosiglitazone; Thiazolidinediones

2009
IL-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity.
    Journal of Korean medical science, 2010, Volume: 25, Issue:4

    Topics: Acute Kidney Injury; Animals; Apoptosis; Caspases; Chemokines; Cisplatin; Cytokines; Enzyme Activation; Hypoglycemic Agents; Interleukin-10; Kidney; Male; Mice; Mice, Inbred BALB C; PPAR gamma; Rosiglitazone; Thiazolidinediones

2010